UniProt ID | RASA2_HUMAN | |
---|---|---|
UniProt AC | Q15283 | |
Protein Name | Ras GTPase-activating protein 2 | |
Gene Name | RASA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 850 | |
Subcellular Localization | Cytoplasm. Cytoplasm, perinuclear region. | |
Protein Description | Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4).. | |
Protein Sequence | MAAAAPAAAAASSEAPAASATAEPEAGDQDSREVRVLQSLRGKICEAKNLLPYLGPHKMRDCFCTINLDQEEVYRTQVVEKSLSPFFSEEFYFEIPRTFQYLSFYVYDKNVLQRDLRIGKVAIKKEDLCNHSGKETWFSLQPVDSNSEVQGKVHLELKLNELITENGTVCQQLVVHIKACHGLPLINGQSCDPYATVSLVGPSRNDQKKTKVKKKTSNPQFNEIFYFEVTRSSSYTRKSQFQVEEEDIEKLEIRIDLWNNGNLVQDVFLGEIKVPVNVLRTDSSHQAWYLLQPRDNGNKSSKTDDLGSLRLNICYTEDYVLPSEYYGPLKTLLLKSPDVQPISASAAYILSEICRDKNDAVLPLVRLLLHHDKLVPFATAVAELDLKDTQDANTIFRGNSLATRCLDEMMKIVGGHYLKVTLKPILDEICDSSKSCEIDPIKLKEGDNVENNKENLRYYVDKLFNTIVKSSMSCPTVMCDIFYSLRQMATQRFPNDPHVQYSAVSSFVFLRFFAVAVVSPHTFHLRPHHPDAQTIRTLTLISKTIQTLGSWGSLSKSKSSFKETFMCEFFKMFQEEGYIIAVKKFLDEISSTETKESSGTSEPVHLKEGEMYKRAQGRTRIGKKNFKKRWFCLTSRELTYHKQPGSKDAIYTIPVKNILAVEKLEESSFNKKNMFQVIHTEKPLYVQANNCVEANEWIDVLCRVSRCNQNRLSFYHPSVYLNGNWLCCQETGENTLGCKPCTAGVPADIQIDIDEDRETERIYSLFTLSLLKLQKMEEACGTIAVYQGPQKEPDDYSNFVIEDSVTTFKTIQQIKSIIEKLDEPHEKYRKKRSSSAKYGSKENPIVGKAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAAPAAA ------CCCHHHHHH | 13.05 | 22223895 | |
48 | Sumoylation | RGKICEAKNLLPYLG CCCHHHHHCCHHHCC | 26.32 | - | |
58 | Acetylation | LPYLGPHKMRDCFCT HHHCCCCCCCCEEEE | 38.47 | 25953088 | |
124 | Acetylation | RIGKVAIKKEDLCNH CCCCEEEEHHHHCCC | 40.13 | 70509 | |
134 | Ubiquitination | DLCNHSGKETWFSLQ HHCCCCCCCCEEEEE | 55.79 | 29967540 | |
208 | Acetylation | GPSRNDQKKTKVKKK CCCCCHHHCCCCCCC | 66.33 | 19608861 | |
209 | Acetylation | PSRNDQKKTKVKKKT CCCCHHHCCCCCCCC | 48.20 | 19608861 | |
211 | Acetylation | RNDQKKTKVKKKTSN CCHHHCCCCCCCCCC | 62.02 | 19608861 | |
213 | Acetylation | DQKKTKVKKKTSNPQ HHHCCCCCCCCCCCC | 50.54 | 19608861 | |
214 | Acetylation | QKKTKVKKKTSNPQF HHCCCCCCCCCCCCC | 65.36 | 133589 | |
216 | Phosphorylation | KTKVKKKTSNPQFNE CCCCCCCCCCCCCCE | 42.49 | 28464451 | |
217 | Phosphorylation | TKVKKKTSNPQFNEI CCCCCCCCCCCCCEE | 56.23 | 28464451 | |
226 | Phosphorylation | PQFNEIFYFEVTRSS CCCCEEEEEEEECCC | 12.42 | 27642862 | |
233 | Phosphorylation | YFEVTRSSSYTRKSQ EEEEECCCCCCCCCC | 24.87 | 26074081 | |
234 | Phosphorylation | FEVTRSSSYTRKSQF EEEECCCCCCCCCCE | 31.60 | 26074081 | |
235 | Phosphorylation | EVTRSSSYTRKSQFQ EEECCCCCCCCCCEE | 16.71 | 26074081 | |
239 | Phosphorylation | SSSYTRKSQFQVEEE CCCCCCCCCEEECHH | 32.70 | 29514088 | |
302 | Ubiquitination | DNGNKSSKTDDLGSL CCCCCCCCCCCCCCE | 64.16 | 24816145 | |
305 | Ubiquitination | NKSSKTDDLGSLRLN CCCCCCCCCCCEEEE | 59.15 | 24816145 | |
308 | Phosphorylation | SKTDDLGSLRLNICY CCCCCCCCEEEEEEE | 20.01 | 24719451 | |
324 | Ubiquitination | EDYVLPSEYYGPLKT CCCCCCHHHHCCHHH | 40.61 | 24816145 | |
357 | Ubiquitination | LSEICRDKNDAVLPL HHHHCCCCCCCHHHH | 37.06 | 24816145 | |
360 | Ubiquitination | ICRDKNDAVLPLVRL HCCCCCCCHHHHHHH | 17.72 | 24816145 | |
379 | Ubiquitination | DKLVPFATAVAELDL CCHHCHHHEEEECCC | 23.26 | 24816145 | |
419 | Ubiquitination | IVGGHYLKVTLKPIL HHCCCEEEEEEHHHH | 26.47 | 32015554 | |
423 | Ubiquitination | HYLKVTLKPILDEIC CEEEEEEHHHHHHHH | 22.20 | 32015554 | |
440 | Ubiquitination | SKSCEIDPIKLKEGD CCCCCCCCCCCCCCC | 31.13 | 24816145 | |
442 | Ubiquitination | SCEIDPIKLKEGDNV CCCCCCCCCCCCCCC | 59.92 | 29967540 | |
462 | Ubiquitination | NLRYYVDKLFNTIVK HHHHHHHHHHHHHHH | 44.96 | - | |
484 | Phosphorylation | VMCDIFYSLRQMATQ HHHHHHHHHHHHHHH | 13.31 | 24719451 | |
501 | Phosphorylation | PNDPHVQYSAVSSFV CCCCCCCHHHHHHHH | 9.48 | 27251275 | |
502 | Phosphorylation | NDPHVQYSAVSSFVF CCCCCCHHHHHHHHH | 12.71 | 27251275 | |
505 | Phosphorylation | HVQYSAVSSFVFLRF CCCHHHHHHHHHHHH | 20.13 | 27251275 | |
506 | Phosphorylation | VQYSAVSSFVFLRFF CCHHHHHHHHHHHHH | 20.87 | 27251275 | |
537 | Phosphorylation | PDAQTIRTLTLISKT CCHHHHHHHHHHHHH | 21.90 | 30576142 | |
542 | Phosphorylation | IRTLTLISKTIQTLG HHHHHHHHHHHHHHH | 27.19 | 30576142 | |
544 | Phosphorylation | TLTLISKTIQTLGSW HHHHHHHHHHHHHCC | 16.13 | - | |
550 | Phosphorylation | KTIQTLGSWGSLSKS HHHHHHHCCCCCCCC | 31.23 | 28348404 | |
553 | Phosphorylation | QTLGSWGSLSKSKSS HHHHCCCCCCCCHHH | 24.18 | 25159151 | |
555 | Phosphorylation | LGSWGSLSKSKSSFK HHCCCCCCCCHHHHH | 36.26 | 28348404 | |
557 | Phosphorylation | SWGSLSKSKSSFKET CCCCCCCCHHHHHHH | 34.10 | 28450419 | |
559 | Phosphorylation | GSLSKSKSSFKETFM CCCCCCHHHHHHHHH | 48.36 | 28450419 | |
560 | Phosphorylation | SLSKSKSSFKETFMC CCCCCHHHHHHHHHH | 44.04 | 28464451 | |
564 | Phosphorylation | SKSSFKETFMCEFFK CHHHHHHHHHHHHHH | 19.77 | 28450419 | |
584 | Ubiquitination | GYIIAVKKFLDEISS CEEEEEHHHHHHHCC | 44.56 | 29967540 | |
591 | Phosphorylation | KFLDEISSTETKESS HHHHHHCCCCCCCCC | 35.60 | 24719451 | |
597 | Phosphorylation | SSTETKESSGTSEPV CCCCCCCCCCCCCCE | 35.31 | 29255136 | |
598 | Phosphorylation | STETKESSGTSEPVH CCCCCCCCCCCCCEE | 47.37 | 29255136 | |
600 | Phosphorylation | ETKESSGTSEPVHLK CCCCCCCCCCCEECC | 31.68 | 29255136 | |
601 | Phosphorylation | TKESSGTSEPVHLKE CCCCCCCCCCEECCC | 43.35 | 28348404 | |
607 | Ubiquitination | TSEPVHLKEGEMYKR CCCCEECCCCHHHHH | 49.12 | 29967540 | |
612 | Phosphorylation | HLKEGEMYKRAQGRT ECCCCHHHHHCCCCC | 7.94 | - | |
651 | Phosphorylation | PGSKDAIYTIPVKNI CCCCCCEEEEEHHHE | 16.82 | 27642862 | |
656 | Ubiquitination | AIYTIPVKNILAVEK CEEEEEHHHEEEEEE | 34.44 | 29967540 | |
759 | Phosphorylation | DIDEDRETERIYSLF ECCCCCCHHHHHHHH | 32.12 | - | |
769 | Phosphorylation | IYSLFTLSLLKLQKM HHHHHHHHHHHHHHH | 5.71 | 20860994 | |
782 | Phosphorylation | KMEEACGTIAVYQGP HHHHHHCEEEEEECC | 1.16 | 22817900 | |
786 | Phosphorylation | ACGTIAVYQGPQKEP HHCEEEEEECCCCCC | 50.95 | 22817900 | |
796 | Phosphorylation | PQKEPDDYSNFVIED CCCCCCCCCCCEEEC | 30.68 | 22817900 | |
808 | Ubiquitination | IEDSVTTFKTIQQIK EECCCCCHHHHHHHH | 42.50 | 29967540 | |
809 | Ubiquitination | EDSVTTFKTIQQIKS ECCCCCHHHHHHHHH | 21.59 | 29967540 | |
812 | Ubiquitination | VTTFKTIQQIKSIIE CCCHHHHHHHHHHHH | 41.02 | 29967540 | |
814 | Ubiquitination | TFKTIQQIKSIIEKL CHHHHHHHHHHHHHC | 31.12 | 29967540 | |
815 | Ubiquitination | FKTIQQIKSIIEKLD HHHHHHHHHHHHHCC | 30.35 | 29967540 | |
816 | Phosphorylation | KTIQQIKSIIEKLDE HHHHHHHHHHHHCCC | 3.91 | 22210691 | |
818 | Ubiquitination | IQQIKSIIEKLDEPH HHHHHHHHHHCCCHH | 45.99 | 29967540 | |
833 | Phosphorylation | EKYRKKRSSSAKYGS HHHHHHHCCCCCCCC | 38.05 | 28634298 | |
834 | Phosphorylation | KYRKKRSSSAKYGSK HHHHHHCCCCCCCCC | 29.99 | 28634298 | |
835 | Phosphorylation | YRKKRSSSAKYGSKE HHHHHCCCCCCCCCC | 15.84 | 28634298 | |
838 | Phosphorylation | KRSSSAKYGSKENPI HHCCCCCCCCCCCCC | 31.38 | 29759185 | |
840 | Phosphorylation | SSSAKYGSKENPIVG CCCCCCCCCCCCCCC | 58.09 | 28122231 | |
847 | Ubiquitination | SKENPIVGKAS---- CCCCCCCCCCC---- | 34.26 | 24816145 | |
848 | Ubiquitination | KENPIVGKAS----- CCCCCCCCCC----- | 17.97 | 24816145 | |
851 | Ubiquitination | PIVGKAS-------- CCCCCCC-------- | 24816145 | ||
869 | Ubiquitination | -------------------------- -------------------------- | 24816145 | ||
870 | Ubiquitination | --------------------------- --------------------------- | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RASA2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RASA2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RASA2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of RASA2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-208; LYS-209; LYS-211 ANDLYS-213, AND MASS SPECTROMETRY. |